The Lismore App
The Lismore App
Your local digital newspaper
Games/PuzzlesBecome a SupporterFlood RecoveryPodcasts
The Lismore App

New prostate cancer treatments put Lismore on the global stage

The Lismore App

30 September 2019, 2:09 AM

New prostate cancer treatments put Lismore on the global stagePictured: Associate Professor Tom Shakespeare.

New prostate cancer treatments offered in Lismore have brought the Northern NSW Local Health District (NNSWLHD) onto the global stage.


NNSWLHD is being recognised as a leader in cancer treatment, with world-first programs that improve healthcare for regional patients. 


Radiation Oncologist with North Coast Cancer Institute Lismore, Associate Professor Tom Shakespeare, is involved in projects evaluating new techniques in prostate cancer treatment, which he showcased at an international conference last week. 


A/Prof Shakespeare presented two papers at the American Society for Radiation Oncology’s (ASTRO) annual meeting in Chicago, which attracts around 10,000 delegates from around the world. 



“The first paper was an evaluation of patient involvement in choosing their cancer treatment through shared decision-making with their oncologist,” A/Prof Shakespeare said. 


Patients involved in the research were provided with a decision aid to help them choose between two radiation therapy options in the cure of prostate cancer. 



“This high degree of patient involvement is a world first, putting the patient at the centre of their care planning alongside their treating specialist.” 


A/ Professor Shakespeare’s second presentation discussed the outcomes of world-leading research involving men from the North and Mid North Coast areas using PET scans to help target radiation therapy to the prostate and lymph nodes. 


“In the past, men with prostate cancer which has spread to the lymph glands were thought to be incurable, but modern advances in radiation therapy and PET scan imaging mean we can offer curative radiation,” he said.


“The early results show that after two years, 100% of patients had their prostate cancer controlled, with minimal side-effects.


“It brings new hope for men whose prostate cancer has escaped from the prostate, that there is a potential for a cure.”


NNSWLHD has a strong focus on clinical trials and quality assurance programs, building on its research and innovation capacity since NCCI first opened in 2010. 


“Everything that we do in research is about helping the people in our community by providing world-class locally-based services,” A/Prof Shakespeare said.

The Lismore App
The Lismore App
Your local digital newspaper


Get it on the Apple StoreGet it on the Google Play Store